Importer of Controlled Substances; Notice of Registration, 28071-28072 [E7-9609]

Download as PDF Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices 28071 section 751(c)(5) of the Act. The Commission found that the domestic interested party group response to its notice of institution (72 FR 4293, January 30, 2007) was adequate and that the respondent interested party group responses with respect to France, Germany, and the United Kingdom were adequate and decided to conduct full reviews with respect to the antidumping duty orders concerning stainless steel bar from France, Germany, and the United Kingdom. The Commission found that the respondent interested party group responses with respect to Italy and Korea were inadequate.1 However, the Commission determined to conduct full reviews concerning the countervailing duty order on stainless steel bar from Italy and the antidumping duty orders on stainless steel bar from Italy and Korea to promote administrative efficiency in light of its decision to conduct full reviews with respect to the orders concerning stainless steel bar from France, Germany, and the United Kingdom. A record of the Commissioners’ votes, the Commission’s statement on adequacy, and any individual Commissioner’s statements will be available from the Office of the Secretary and at the Commission’s Web site. Schedule INTERNATIONAL TRADE COMMISSION [Investigation Nos. 701–TA–413 and 731– TA–913–916 and 918 (Review)] Stainless Steel Bar From France, Germany, Italy, Korea, and The United Kingdom United States International Trade Commission. ACTION: Notice of Commission determinations to conduct full five-year reviews concerning the countervailing duty order on stainless steel bar from Italy and the antidumping duty orders on stainless steel bar from France, Germany, Italy, Korea, and the United Kingdom. pwalker on PROD1PC71 with NOTICES AGENCY: SUMMARY: The Commission hereby gives notice that it will proceed with full reviews pursuant to section 751(c)(5) of the Tariff Act of 1930 (19 U.S.C. 1675(c)(5)) to determine whether revocation of the countervailing duty order on stainless steel bar from Italy and the antidumping duty orders on stainless steel bar from France, Germany, Italy, Korea, and the United Kingdom would be likely to lead to continuation or recurrence of material injury within a reasonably foreseeable time. A schedule for the reviews will be established and announced at a later date. For further information concerning the conduct of these reviews and rules of general application, consult the Commission’s Rules of Practice and Procedure, part 201, subparts A through E (19 CFR part 201), and part 207, subparts A, D, E, and F (19 CFR part 207). EFFECTIVE DATE: May 7, 2007. FOR FURTHER INFORMATION CONTACT: Mary Messer (202–205–3193), Office of Investigations, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436. Hearingimpaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (https:// www.usitc.gov). The public record for these reviews may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. SUPPLEMENTARY INFORMATION: On May 7, 2007, the Commission determined that it should proceed to full reviews in the subject five-year reviews pursuant to VerDate Aug<31>2005 17:06 May 17, 2007 Jkt 211001 Authority: These reviews are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.62 of the Commission’s rules. By order of the Commission. Issued: May 14, 2007. William R. Bishop, Acting Secretary to the Commission. [FR Doc. E7–9560 Filed 5–17–07; 8:45 am] Drug 1-[1-(2–Thienyl) cyclohexyl] piperidine; TCP (7470). Normorphine (9313) ..................... Dextropropoxyphene, bulk (nondosage form) (9273). I I II The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of American Radiolabeled Chemical, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated American Radiolabeled Chemical, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: May 14, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–9611 Filed 5–17–07; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration Manufacturer of Controlled Substances; Notice of Registration By Notice dated February 14, 2007 and published in the Federal Register on February 22, 2007, (72 FR 8017), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in schedule II. The company plans to import Phenylacetone for use as a precursor in the manufacture of amphetamines only. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of By Notice dated January 23, 2007, and published in the Federal Register on January 30, 2007, (72 FR 4296), American Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: 1 Commissioners Lane and Williamson dissented with respect to the adequacy of the Italian respondent interested party group response, finding that the Italian respondent interested party group response was adequate. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\18MYN1.SGM 18MYN1 28072 Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices Cambrex Charles City, Inc. to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: May 14, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–9609 Filed 5–17–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: May 14, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–9625 Filed 5–17–07; 8:45 am] BILLING CODE 4410–09–P Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated January 16, 2007, and published in the Federal Register on January 23, 2007, (72 FR 2907), Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: pwalker on PROD1PC71 with NOTICES Drug Tetrahydrocannabinols (7370) ..... Dihydromorphine (9145) ............... Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ Remifentanil (9739) ...................... 17:06 May 17, 2007 Jkt 211001 Schedule I I II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cedarburg Pharmaceuticals, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Cedarburg Pharmaceuticals, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of PO 00000 Frm 00054 Fmt 4703 BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Registration DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Registration VerDate Aug<31>2005 Dated: May 14, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–9642 Filed 5–17–07; 8:45 am] Drug Enforcement Administration Drug Enforcement Administration By Notice dated October 25, 2006, and published in the Federal Register on November 1, 2006, (71 FR 64298), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Sufentanil (9740), a basic class of controlled substance listed in schedule II. The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambrex Charles City, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. the basic classes of controlled substances listed. Sfmt 4703 By Notice dated November 21, 2006, and published in the Federal Register on December 1, 2006, (71 FR 69589– 69590), Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal and by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug 4–Methoxyamphetamine (7411) ... Dihydromorphine (9145) ............... Difenoxin (9168) ........................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Pentobarbital (2270) ..................... Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Meperidine (9230) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Alfentanil (9737) ........................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ Schedule I I I II II II II II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. By letter dated February 15, 2007, Chattem Chemicals has withdrawn their request for N-Ethylamphetamine (1475), Secobarbital (2315), 2,5– Dimethoxyamphetamine (7396), Diphenoxylate (9170), Opium Extracts (9610), Opium Fluid Extract (9620), Opium Tincture (9630), Opium Powdered (9639), and Opium Granulated (9640). One comment has been received; this comment has been noted and considered by DEA. E:\FR\FM\18MYN1.SGM 18MYN1

Agencies

[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Pages 28071-28072]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-9609]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated February 14, 2007 and published in the Federal 
Register on February 22, 2007, (72 FR 8017), Cambrex Charles City, 
Inc., 1205 11th Street, Charles City, Iowa 50616, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of Phenylacetone (8501), a basic class of controlled 
substance listed in schedule II.
    The company plans to import Phenylacetone for use as a precursor in 
the manufacture of amphetamines only.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of

[[Page 28072]]

Cambrex Charles City, Inc. to import the basic class of controlled 
substance is consistent with the public interest and with United States 
obligations under international treaties, conventions, or protocols in 
effect on May 1, 1971, at this time. DEA has investigated Cambrex 
Charles City, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with State and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, 
the above named company is granted registration as an importer of the 
basic class of controlled substance listed.

    Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-9609 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.